| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.23 | 1e-10 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.22 | 6e-10 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.2 | 4e-09 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.2 | 1e-08 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.21 | 1e-08 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.2 | 1e-08 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.21 | 9e-08 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.2 | 1e-07 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-07 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-07 |